search
Back to results

DNA Typing of HLA-DR/DQ Alleles in Taiwan Chinese With Rheumatic Heart Disease

Primary Purpose

Rheumatic Heart Disease

Status
Completed
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
venipuncture to withdraw patient's blood
Sponsored by
China Medical University Hospital
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Rheumatic Heart Disease focused on measuring Rheumatic heart disease, HLA, Genetics, Taiwan

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)

Inclusion Criteria: 1.Patients with Rheumatic mitral stenosis 2.Chinese Han ethnicity Exclusion Criteria: -

Sites / Locations

  • Division of cardiology, China Medical University Hospital

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
December 12, 2005
Last Updated
November 26, 2010
Sponsor
China Medical University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT00264524
Brief Title
DNA Typing of HLA-DR/DQ Alleles in Taiwan Chinese With Rheumatic Heart Disease
Study Type
Interventional

2. Study Status

Record Verification Date
January 2004
Overall Recruitment Status
Completed
Study Start Date
January 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
July 2005 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
China Medical University Hospital

4. Oversight

5. Study Description

Brief Summary
The current study was designed to determine whether the HLA-DRB1, DQA1, DQB1 alleles are associated with the risk and the pattern of valve damage of RHD.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rheumatic Heart Disease
Keywords
Rheumatic heart disease, HLA, Genetics, Taiwan

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Masking
None (Open Label)
Allocation
Non-Randomized

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
venipuncture to withdraw patient's blood

10. Eligibility

Eligibility Criteria
Inclusion Criteria: 1.Patients with Rheumatic mitral stenosis 2.Chinese Han ethnicity Exclusion Criteria: -
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hsiang-Tai Chou, MD, PhD
Organizational Affiliation
China Medical University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Division of cardiology, China Medical University Hospital
City
Taichung
ZIP/Postal Code
403
Country
Taiwan

12. IPD Sharing Statement

Learn more about this trial

DNA Typing of HLA-DR/DQ Alleles in Taiwan Chinese With Rheumatic Heart Disease

We'll reach out to this number within 24 hrs